Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 23, 2026

Jan. 23, 2026

Protecting Football Players’ Brains: Breakthrough Study Reinforces Vielight’s Red-Light Therapy Technology

GlobeNewswire

Jan. 23, 2026

Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

GlobeNewswire

Jan. 23, 2026

Nexalin Technology Receives Nasdaq Listing Status Notification

GlobeNewswire

Jan. 23, 2026

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M

GlobeNewswire

Jan. 23, 2026

MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity

GlobeNewswire

Jan. 23, 2026

CAPNOS LEGURA Vape Replacement Investigated: 2026 Consumer Analysis Examines Nicotine-Free Behavioral Aid Technology and Safety Documentation

GlobeNewswire

Jan. 23, 2026

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Jan. 23, 2026

Receipt of Delinquency Notification from Nasdaq

GlobeNewswire

Jan. 23, 2026

Synevra UltraLift Ingredients Investigated: 2026 Consumer Analysis Examines Peptide Serum Formula and Dual-Action Skincare System Disclosures

GlobeNewswire

Jan. 23, 2026

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

GlobeNewswire

Jan. 23, 2026

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency

GlobeNewswire

Jan. 23, 2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Jan. 23, 2026

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Jan. 23, 2026

Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

Jan. 23, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

GlobeNewswire

Jan. 23, 2026

Aja Health and Wellness Inc. Announces Agreement Between Assured Diagnosis Inc. and Greatway Financial Inc. and Implementation of New Electronic Medical Records Software for GOeVisit

GlobeNewswire

Jan. 23, 2026

Calgary Health Foundation commits $1 million to expand bariatric care with Assisted Living Alberta

GlobeNewswire

Jan. 23, 2026

Upsize™ Clinic Opens 23rd Location in Greenwood Village, Bringing Advanced Male Enhancement Procedures to the Denver Metro Area

GlobeNewswire

Jan. 23, 2026

AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering

GlobeNewswire

Jan. 23, 2026

NUTRAHARMONY Recognized as Best Organic Lymphatic Drainage Drops in 2026 by SupplementInsight

GlobeNewswire